Preferences help
enabled [disable] Abstract
Number of results
2015 | 5 | 1 | A27-A32
Article title

Therapeutic rehabilitation of cancer patients. Why and what for?

Title variants
Languages of publication
Types of oncological rehabilitation and its objectives are described. It includes information on many manifestations of oncological diseases that an internist has to deal with, which are conditioned not only by the oncological process itself, but by the cancer treatment conducted, as well as the attitude of doctors and patients to cancer pathology. The specific characteristics of the “cancer disease” are described, as well as a combination of somatic disorders which depends on the ongoing or arrested tumor development. It is necessary for doctors to observe the cancer patients before, during and after treatment for complication of cancer or treatment over the life span.
Physical description
  • Saint-Petersburg Clinical Hospital, Russian Academy of Sciences
  • Saint-Petersburg Clinical Hospital, Russian Academy of Sciences
  • Saint-Petersburg Clinical Hospital, Russian Academy of Sciences
  • Saint-Petersburg Clinical Hospital, Russian Academy of Sciences
  • Dietz JH. Rehabilitation oncology. Wiley, New York 1981.
  • Michael D. Stubblefield, Michael O’Dell. Cancer Rehabilitation: Principles and Practice (Hardback). Demos Medical Publishing, New York 2009.
  • Hinterbuchner C. Rehabilitation of a physical disability in cancer. NY State J Med. 1978; 78: 1066-1069.
  • Hismatullina ZN. Palliative support to incurable patients as part of social and medical activities in oncology. Sovremennye problemy nauki i obrazovanija. 2007; 4: 41-45 (in Russian).
  • Palliative care to oncologic patients: Teaching guide. Novikov GA, Chissov VI. (red.). M.: OOD «Medicina za kachestvo zhizni»; 2006 (in Russian).
  • Kristjan TR, David CTh. The Cancer rehabilitation and adaptation team. Holland-Frei Cancer Medicine. 6th edition, 2003.
  • Petrov NN. General study about tumors (pathology and clinic). Petrograd: Izdanie zhurnala «Gigiena i sanitarija» 1910 (in Russian).
  • Petrov NN. Chemical and biological methods of the recognition of the cancerous disease. Petrograd: Prakticheskaja medicina 1914 (in Russian).
  • Ballyuzek M, Stepanov BP. Tasks and opportunities of therapeutic rehabilitation of cancer patients. Klinicheskaja meditsina. 2013; 9: 53-57 (in Russian).
  • Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf. 2000; 22(4): 263-302.
  • Yeh ET, Tong AT, Lenihan DJ et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004; 109(25): 3122-3131.
  • Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2011; 86(4): 364.
  • Bozzetti F. Nutrition support in patients with cancer. Greenwich Medical Media Ltd, London 2001.
  • Umar SB, DiBaise JK. Protein-losing enteropathy: case illustrations and clinical review protein-losing enteropathy. Am J Gastroenterol. 2010; 105: 43-49.
  • Сhong VH, Lim CC. Erythroderma as the first manifestation of colon cancer. South Med J. 2009; 102: 334-335.
  • Palapattu GS, Kristo B, Rajfer J. Paraneoplastic syndromes in urologic malignancy: the faces of renal cell carcinoma. Rev Urol. 2002; 4(4): 163-170.
  • DeLellis RA, Ling X. Paraneoplastics endocrine syndromes: A review. Endocrine Pathology. 2003; 14(4): 303-317.
  • Sørensen HT, Mellemkjaer L, Skriver MV et al. Fever of unknown origin and cancer: a population-based study. Lancet Oncol. 2005; 6(11): 851-855.
  • Bleeker-Rovers CP, Vos FJ, de Kleijn EM et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007; 86(1): 26-38.
  • Bleeker-Rovers CP, van der Meer JW, Oyen WJ. Fever of unknown origin. Semin Nucl Med. 2009; 39(2): 81-87.
  • Racanelli V, Prete M, Minoia C, et al. Rheumatic disorders as paraneoplastic syndromes. Autoimmunity Reviews 2008; 7: 352-358.
  • Shambers S, Isinberg D. Malignancy and rheumatic disease – a real association. J Rheumatol. 2005; 10: 1884-1887.
  • Rugienė R, Dadonienė J, Aleknavičius E. et al. Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours. Clin Rheumatol. 2011; 30: 373-380.
  • Mauricio O, Francis L, Athar U et al. Hypertrophic osteoarthropathy masquerading as lower extremity cellulitis and response to bisphosphonates. J Thorac Oncol. 2009; 4: 260-262.
  • Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008; 7: 327-340.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.